Long-Term Central Venous Catheters

One Patient, One Catheter

A Central Venous Catheter that puts your patient first.

Selecting the right vascular access device has become more important — particularly for patients with renal issues, chronic patients with poor peripheral access or those with a history of, or risk for, venous thrombosis. The Arrowg+ard Blue Advance JACC is a state-of-the-art alternative to traditional acute CVCs and peripheral central venous access. This new CVC, for acute or long-term use, combines antimicrobial and antithrombogenic protection with smaller french sizes to meet the unique challenges posed by some patients today.

Types of Patients Who Can Benefit from the Arrowg+ard Blue Advance JACC


  1. Collins JL, Lutz RJ. In vitro Study of Simultaneous Infusion of Incompatible Drugs in Multilumen Catheters. Heart & Lung. 1991; 20(3):271-7 * Single- and double-lumen catheters have a maximum flow rate of 5 mL/sec
Rx only No correlation between in vitro / in vivo testing methods and clinical outcomes have currently been ascertained. Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Advance, ErgoPack, Meet JACC, and Never Settle are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners. MC-004521